Tactile Systems Technology Revenue 2015-2025 | TCMD

Tactile Systems Technology revenue from 2015 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Tactile Systems Technology Annual Revenue
(Millions of US $)
2024 $293
2023 $274
2022 $247
2021 $208
2020 $187
2019 $189
2018 $144
2017 $109
2016 $85
2015 $63
2014 $48
Tactile Systems Technology Quarterly Revenue
(Millions of US $)
2025-06-30 $79
2025-03-31 $61
2024-12-31 $86
2024-09-30 $73
2024-06-30 $73
2024-03-31 $61
2023-12-31 $78
2023-09-30 $70
2023-06-30 $68
2023-03-31 $59
2022-12-31 $74
2022-09-30 $65
2022-06-30 $60
2022-03-31 $48
2021-12-31 $62
2021-09-30 $52
2021-06-30 $51
2021-03-31 $43
2020-12-31 $59
2020-09-30 $49
2020-06-30 $35
2020-03-31 $44
2019-12-31 $57
2019-09-30 $50
2019-06-30 $45
2019-03-31 $38
2018-12-31 $46
2018-09-30 $36
2018-06-30 $34
2018-03-31 $27
2017-12-31 $35
2017-09-30 $28
2017-06-30 $26
2017-03-31 $20
2016-12-31 $28
2016-09-30 $23
2016-06-30 $20
2016-03-31 $14
2015-12-31 $21
2015-09-30 $17
2015-06-30 $15
2015-03-31 $10
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.529B $0.293B
Tactile Systems Technology, Inc. is a medical technology company which develops medical devices for the treatment of chronic diseases at home. The company's product pipeline consists of Flexitouch System(R), the Entr? System and the ACTitouch System (R). Tactile Systems Technology, Inc. is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $217.426B 25.83
Intuitive Surgical (ISRG) United States $196.986B 77.07
IDEXX Laboratories (IDXX) United States $55.092B 54.71
Edwards Lifesciences (EW) United States $50.080B 33.58
Alcon (ALC) Switzerland $38.300B 25.88
IQVIA Holdings (IQV) United States $37.570B 20.95
Mettler-Toledo (MTD) United States $28.663B 33.53
STERIS (STE) Ireland $25.362B 26.18
DexCom (DXCM) United States $22.644B 31.22
Waters (WAT) United States $22.587B 29.87
Hologic (HOLX) United States $16.492B 17.36
SONOVA HOLDING (SONVY) Switzerland $15.115B 0.00
Globus Medical (GMED) United States $11.303B 23.72
Penumbra (PEN) United States $10.968B 77.15
Masimo (MASI) United States $8.117B 26.01
Sysmex ADR (SSMXY) Japan $6.351B 20.18
Glaukos (GKOS) United States $5.171B 0.00
Teleflex (TFX) United States $4.729B 7.54
TransMedics (TMDX) United States $3.930B 46.56
Veracyte (VCYT) United States $3.111B 35.45
LivaNova (LIVN) United Kingdom $3.023B 16.33
Alphatec Holdings (ATEC) United States $2.932B 0.00
Integer Holdings (ITGR) United States $2.435B 11.43
Artivion (AORT) United States $2.165B 99.35
Nihon Kohden (NHNKY) Japan $2.021B 17.64
Elekta AB (EKTAY) Sweden $1.737B 16.83
PROCEPT BioRobotics (PRCT) United States $1.659B 0.00
Tandem Diabetes Care (TNDM) United States $1.262B 0.00
Beta Bionics (BBNX) United States $1.197B 0.00
AxoGen (AXGN) United States $1.086B 0.00
IRadimed (IRMD) United States $1.073B 51.12
OPKO Health (OPK) United States $0.983B 0.00
Pulse Biosciences (PLSE) United States $0.976B 0.00
Integra LifeSciences Holdings (IART) United States $0.915B 4.96
SiBone (SIBN) United States $0.756B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.592B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.529B 10.55
AngioDynamics (ANGO) United States $0.499B 0.00
Pacific Biosciences Of California (PACB) United States $0.486B 0.00
ClearPoint Neuro (CLPT) United States $0.439B 0.00
NeuroPace (NPCE) United States $0.431B 0.00
OrthoPediatrics (KIDS) United States $0.419B 0.00
Mesa Laboratories (MLAB) United States $0.408B 11.27
RxSight (RXST) United States $0.400B 0.00
Sight Sciences (SGHT) United States $0.376B 0.00
Semler Scientific (SMLR) United States $0.331B 2.49
Delcath Systems (DCTH) United States $0.315B 52.53
Alpha Tau Medical (DRTS) Israel $0.315B 0.00
Spectral Diagnostics (EDTXF) Canada $0.295B 0.00
CVRx (CVRX) United States $0.243B 0.00
908 Devices (MASS) United States $0.198B 0.00
Treace Medical Concepts (TMCI) United States $0.193B 0.00
Inogen (INGN) United States $0.187B 0.00
Rapid Micro Biosystems (RPID) United States $0.187B 0.00
Anteris Technologies Global (AVR) Australia $0.152B 0.00
Lucid Diagnostics (LUCD) United States $0.147B 0.00
Microbot Medical (MBOT) United States $0.139B 0.00
Neuronetics (STIM) United States $0.136B 0.00
LENSAR (LNSR) United States $0.121B 0.00
Accuray (ARAY) United States $0.118B 0.00
Atossa Genetics (ATOS) United States $0.103B 0.00
Zomedica (ZOMDF) United States $0.094B 0.00
Hyperfine (HYPR) United States $0.090B 0.00
InspireMD (NSPR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.079B 0.00
QT Imaging Holdings (QTIH) United States $0.075B 0.00
Sensus Healthcare (SRTS) United States $0.071B 0.00
Spectral AI (MDAI) United States $0.047B 0.00
Baird Medical Investment Holdings (BDMD) $0.045B 0.00
Precision Optics (POCI) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Vicarious Surgical (RBOT) United States $0.019B 0.00
Envoy Medical (COCH) United States $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.012B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
Tenon Medical (TNON) United States $0.010B 0.00
PAVmed (PAVM) United States $0.009B 0.00
EnVVeno Medical (NVNO) United States $0.008B 0.00
Solana (HSDT) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
WORK Medical Technology Group (WOK) China $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 11.24
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00